This page is part of the Evidence Based Medicine on FHIR Implementation Guide (v1.0.0-ballot2: STU1 Ballot 2) based on FHIR (HL7® FHIR® Standard) v6.0.0. No current official version has been published yet. For a full list of available versions, see the Directory of published versions

• Narrative Content
• XML
• JSON
• TTL

: GLP-1 RA Group in Adults with diabetes type 2 with moderate CV risk - XML Representation

Raw xml | Download

<Group xmlns="http://hl7.org/fhir">
  <id value="236535"/>
  <meta>
    <versionId value="74"/>
    <lastUpdated value="2025-03-25T23:13:32.858Z"/>
    <profile
             value="http://hl7.org/fhir/uv/ebm/StructureDefinition/exposure-group"/>
  </meta>
  <text>
    <status value="empty"/>
    <div xmlns="http://www.w3.org/1999/xhtml"><p>[No data.]</p></div>
  </text>
  <extension url="http://hl7.org/fhir/StructureDefinition/artifact-author">
    <valueContactDetail>
      <name value="Computable Publishing®: MAGIC-to-FEvIR Converter"/>
    </valueContactDetail>
  </extension>
  <extension url="http://hl7.org/fhir/uv/ebm/StructureDefinition/cite-as">
    <valueMarkdown
                   value="GLP-1 RA Group in Adults with diabetes type 2 with moderate CV risk [Database Entry: FHIR Group Resource]. Contributors: Computable Publishing®: MAGIC-to-FEvIR Converter [Authors/Creators]. In: Fast Evidence Interoperability Resources (FEvIR) Platform, FOI 236535. Revised 2025-03-20. Available at: https://fevir.net/resources/Group/236535. Computable resource at: https://fevir.net/resources/Group/236535#json."/>
  </extension>
  <url value="https://fevir.net/resources/Group/236535"/>
  <identifier>
    <type>
      <coding>
        <system value="http://terminology.hl7.org/CodeSystem/v2-0203"/>
        <code value="ACSN"/>
        <display value="Accession ID"/>
      </coding>
      <text value="FEvIR Object Identifier"/>
    </type>
    <system value="urn:ietf:rfc:3986"/>
    <value value="https://fevir.net/FOI/236535"/>
    <assigner>
      <display value="Computable Publishing LLC"/>
    </assigner>
  </identifier>
  <identifier>
    <type>
      <text value="FEvIR Linking Identifier"/>
    </type>
    <system value="https://fevir.net/FLI"/>
    <value
           value="MAGIC-5288-j1Wqrn-intervention-group-MAGIC-5288-j1Wqrn-intervention-85390-I-85789"/>
    <assigner>
      <display value="Computable Publishing LLC"/>
    </assigner>
  </identifier>
  <title
         value="GLP-1 RA Group in Adults with diabetes type 2 with moderate CV risk"/>
  <status value="active"/>
  <publisher value="Computable Publishing LLC"/>
  <contact>
    <telecom>
      <system value="email"/>
      <value value="support@computablepublishing.com"/>
    </telecom>
  </contact>
  <description value="Glucagon-Like Peptide-1 (GLP-1) receptor agonists"/>
  <useContext>
    <code>
      <system value="https://fevir.net/resources/CodeSystem/179423"/>
      <code value="evidence-communication"/>
      <display value="Evidence Communication"/>
    </code>
    <valueCodeableConcept>
      <coding>
        <system value="https://fevir.net/resources/CodeSystem/179423"/>
        <code value="ExposureGroup"/>
        <display value="ExposureGroup"/>
      </coding>
    </valueCodeableConcept>
  </useContext>
  <copyright value="https://creativecommons.org/licenses/by-nc-sa/4.0/"/>
  <type value="person"/>
  <membership value="enumerated"/>
  <combinationMethod value="all-of"/>
  <characteristic>
    <code>
      <text value="Member of"/>
    </code>
    <valueReference>🔗 
      <reference value="Group/236533"/>
      <type value="Group"/>
      <identifier>
        <type>
          <text value="FEvIR Linking Identifier"/>
        </type>
        <system value="https://fevir.net/FLI"/>
        <value value="MAGIC-5288-j1Wqrn-population-group-85390-85789"/>
        <assigner>
          <display value="Computable Publishing LLC"/>
        </assigner>
      </identifier>
      <display
               value="Adults with type 2 diabetes and established CVD (but no CKD)"/>
    </valueReference>
    <exclude value="false"/>
    <description
                 value="inclusion in Adults with type 2 diabetes with moderate CV risk"/>
  </characteristic>
  <characteristic>
    <code>
      <text value="Exposed to"/>
    </code>
    <valueReference>🔗 
      <reference value="Group/236532"/>
      <type value="Group"/>
      <identifier>
        <type>
          <text value="FEvIR Linking Identifier"/>
        </type>
        <system value="https://fevir.net/FLI"/>
        <value value="MAGIC-5288-j1Wqrn-intervention-85390-I-85789"/>
        <assigner>
          <display value="Computable Publishing LLC"/>
        </assigner>
      </identifier>
      <display value="Glucagon-Like Peptide-1 (GLP-1) receptor agonists"/>
    </valueReference>
    <exclude value="false"/>
    <description value="received GLP-1 RA"/>
  </characteristic>
</Group>